DUBLIN, Ohio – Cardinal Health and Cook Medical today
announced a two-year, exclusive agreement for the North American distribution
of Cook Medical central venous catheter (CVC) sets with Cardinal Health
Presource® customizable procedural kits ? providing clinicians with advanced
technology the flexibility of customization for their vascular access needs.
Under the agreement, Cardinal Health and Cook Medical
customers are now able to customize components of their CVC procedural kits. The
kits can include either uncoated or Cook Spectrum® CVC sets, which feature the
industrys highest flow rates and a comprehensive product line including
power-injectable catheters. The partnership enables acute care providers to maximize
value and minimize waste by providing a cost-effective means to decrease the
number of supplies they need to supplement standard CVC procedural kits.
“Were thrilled to partner with Cardinal Health, an industry
leader in custom kitting, to expand access to Cook Medicals CVC sets for
vascular access professionals,” said Dan Sirota, vice president and business
unit leader of Cook Medicals Critical Care and Interventional Radiology
divisions. “Improving patient care and lowering health care costs are of utmost
importance to hospitals. We remain committed to offering solutions that streamline
processes for clinicians and empower them to provide top-quality patient care.”
Cook Medicals Spectrum catheters are impregnated with the
antibiotics minocycline and rifampin and meet the newly released 1A
recommendation from the CDC for reducing catheter-related bloodstream
infections (CRBSIs) if maximal sterile barrier precautions havent helped a
facility reach its [infection prevention] goal.1 An estimated 78,000 patients are
infected with potentially fatal CRBSIs in the U.S. annually, with an average
cost estimated at $16,550 per infection.2 Spectrum catheters have been shown to
be five times less likely to produce infection than process alone.3
“Cardinal Health focuses on developing partnerships that
deliver innovative solutions that help make it easier for our customers to
deliver high quality care,” said Lisa Ashby, president of category management
at Cardinal Health. “Our relationship with Cook Medical is a great example of
the kinds of partnerships our customers value – those that promote best
practice standardization with superior quality products.”
Headquartered in Dublin, Ohio, Cardinal Health, Inc. is a $103
billion health care
services company that improves the
cost-effectiveness of health care. As the business behind health care, Cardinal
Health helps pharmacies, hospitals, ambulatory surgery centers and physician offices focus on
patient care while reducing costs, enhancing efficiency and
Cardinal Health is an essential link in the health care supply chain, providing
pharmaceuticals and medical products to more
than 60,000 locations each day. The company is also a leading manufacturer of medical
and surgical products, including gloves, surgical apparel and fluid management products.
In addition, the company supports the growing diagnostic industry by supplying
medical products to clinical laboratories and
operating the nation’s largest network of radiopharmacies that
dispense products to aid in the early diagnosis and treatment of disease.
Ranked #19 on the Fortune 500, Cardinal Health employs more than 30,000 people worldwide.
More information about the company may be found at cardinalhealth.com and @CardinalHealth on Twitter.
About Cook Medical
A global pioneer in medical breakthroughs, Cook Medical is committed to
creating effective solutions that benefit millions of patients worldwide.
Today, we combine medical devices, drugs, biologic grafts and cell therapies
across more than 16,000 products serving more than 40 medical specialties.
Founded in 1963 by a visionary who put patient needs and ethical business
practices first, Cook is a family-owned company that has created more than
10,000 jobs worldwide. For more information, visit www.cookmedical.com. Follow Cook Medical
on Twitter and LinkedIn.
1 OGrady NP, Alexander M, Burns LA, et al. Guidelines for the prevention of
intravascular catheter-related infections. Am J Infect Control. 2011;39(4 suppl
2 Centers for Disease Control and Prevention. Vital Signs: central
line-associated blood stream infections–United States, 2001, 2008, and 2009. MMWR
Morb Mortal Wkly Rep. 2011:60(8): 243-2488
3 Hanna H, Benjamin R, Chatzinikolaou I, et al. “Long-term silicone
central venous catheters impregnated with minocycline and rifampin decrease rates
of catheter-related bloodstream infection in cancer patients: a prospective randomized
clinical trial;” J Clin Oncol. 2004; 22(15):3163-3171.